 |
2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine |
|---|---|
| Trade Name | |
| Orphan Indication | Charcot-Marie-Tooth disease |
| EU Market Approval | EU |
| EU Designation Date | 2017-10-16 00:00:00 |
| Sponsor | Repositioning SAS |
| |
2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine |
|---|---|
| Trade Name | |
| Orphan Indication | Charcot-Marie-Tooth disease |
| EU Market Approval | EU |
| EU Designation Date | 2017-10-16 00:00:00 |
| Sponsor | Repositioning SAS |